Dr Karim Kohansal Vajargah

Karim is a clinician scientist with a background in cardiovascular medicine and a focus on genetic epidemiology. He earned his Doctor of Medicine from Shahid Beheshti University of Medical Sciences in Tehran, where his research focused on cardiometabolic-related outcomes in Iranian and American population-based cohorts.

He has over three years of clinical experience as a general practitioner and has contributed to more than a dozen peer-reviewed publications in leading cardiovascular journals. Karim’s work has focused on the links between heart failure, kidney function, and metabolic health, and on leveraging human genetics to uncover causal mechanisms and therapeutic targets. Alongside his clinical work, Karim collaborated with the University of Pennsylvania, where he integrated multi-omics and Mendelian randomization approaches to investigate vascular aging and heart failure pathophysiology.

At Sequoia Genetics, Karim integrates clinical, public health, and epidemiological perspectives into drug development, providing human-centric insights to clients across the pharmaceutical and biotechnology sectors.